Stuart Paynter

Stuart Paynter is the current Chief Financial Officer at Oxford BioMedica. Stuart has over 20 years of experience in finance and accounting, having worked their way up from a Financial Analyst at Unigraphics Solutions to their current role. Stuart has a proven track record in leading and delivering finance strategies that support business growth. Stuart has extensive experience in FP&A, auditing, and financial operations.

Stuart Paynter has a BSc (Hons) in ARCS from Imperial College London and is a FCA (Chartered Accountancy) from ICAEW.

Stuart Paynter reports to John Dawson, Chief Executive Officer. They are on a team with Jason Slingsby - Chief Business Officer, Dmitry Zamoryakhin - Chief Medical Officer, and Nick Page - Chief Operations Officer.